CPR's Lifesaving Powers Decline as Minutes Pass
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
THURSDAY, Feb. 8, 2024 -- CPR can save lives, but its ability to restore heart function goes from slim to none in a shockingly short time, a new study finds.
How short? A person’s chance of surviving cardiac arrest while receiving CPR declines from 22% after one minute of chest compressions to less than 1% after 39 minutes of compressions, researchers report Feb. 7 in the BMJ.
Meanwhile, the chance of escaping major brain damage from cardiac arrest declines from 15% after one minute of CPR to less than 1% after 32 minutes with no re-established heartbeat.
These results could help guide the grim decision of when to stop applying CPR to a patient whose heart is not responding.
“The findings provide resuscitation teams, patients and their surrogates with insights into the likelihood of favorable outcomes if patients pending the first return of spontaneous circulation continue to receive further cardiopulmonary resuscitation,” concluded the study led by Dr. Masashi Okubo, a clinical assistant professor of emergency medicine at the University of Pittsburgh.
About 300,000 cardiac arrests happen in a hospital every year, researchers noted, and about 25% of those patients survive to hospital discharge.
In the study, Okubo's team measured CPR duration for nearly 350,000 U.S. adults who had an in-hospital cardiac arrest between 2000 and 2021, using the largest dataset of such cases available in the world.
They found that two-thirds of patients (67%) responded to CPR within an average of seven minutes, while 33% failed to re-establish a heartbeat after an average 20 minutes of CPR.
Overall, about 23% of cardiac arrest patients survived to hospital discharge in this study.
“Most termination of resuscitation occurred before the time point of traditional medical futility,” or the point at which survival odds are less than 1%, the researchers noted in a journal news release.
“Further research is needed to evaluate whether patients’ outcomes would improve with prolonged cardiopulmonary resuscitation before termination of resuscitation,” the team continued.
They proposed a future clinical trial in which one group of patients receives CPR for as long as their doctors deem necessary, while a second group receives CPR for a predetermined -- and likely longer -- amount of time.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-08 22:15
Read more
- Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer
- Texas AG Sues Dallas Doctor Over Transgender Care for Minors
- Older People More Prone to Relocating After Dementia Diagnosis
- Darling Ingredients Announces Publication of Peer-Reviewed Collagen Peptides Study and its Impact on Post-Meal Blood Glucose Spikes
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions